首页>
外国专利>
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF FUNCTIONAL DYSPEPSY AND / OR THE IRRIDAL SYNDROME AND THE USE OF NEW SUBSTANCES IN THIS COMPOSITION
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF FUNCTIONAL DYSPEPSY AND / OR THE IRRIDAL SYNDROME AND THE USE OF NEW SUBSTANCES IN THIS COMPOSITION
展开▼
机译:用于治疗功能性消化不良和/或虹膜综合症的药物组合物,以及在该组合物中使用新物质的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
The use of a gastrointestinal peptide hormone, selected from glucagon-like peptide-1 (GLP-1) and its derivatives having anti-secretory effects and smooth muscle relaxatory properties in the gastrointestinal tract, for the manufacture of a pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome, is new. Independent claims are also included for the following: (1) a pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome characterized in that it comprises a combination of at least one member selected from GLP-1 and its derivatives having anti-secretory effects and smooth muscle relaxatory properties in the gastrointestinal tract with one or two more other gastrointestinal peptide hormone(s) and their derivatives having such effects and properties together with additives; and (2) a method for the treatment of functional dyspepsia or irritable bowel syndrome or both in a human patient, comprising administering the composition of (1). ACTIVITY : Anti-inflammatory. MECHANISM OF ACTION : GLP-1 is a gastrointestinal peptide hormone with antisecretory effects and smooth muscle relaxatory properties within the gastrointestinal tract.
展开▼